Filippo Cipriani Email & Phone Number | With experience both in private and public sector, I am a Market Access – Public Affairs – Pt Advocacy – Communication expert and enthusiast, always looking for original approaches to ameliorate people lives. In the past 15 years, I covered different roles, at national and international level, dealing with multiple therapeutic areas, developing value stories and communication campaigns, executing price (re)negotiations and supporting commercial launches in Vaccines, Rare Diseases and Rare Blood Disorders, Multiple Sclerosis, Oncology, Endocrinology and Immunology. Since 2015, I lead MAKEtoCARE, a multi-stakeholder initiative, with multiple spin-offs, to fight disability. Started as a contest to celebrate bottom-up patient-driven innovation it later evolved in a research project and in public-private alliances. Most recent papers: Implications of Atopic Dermatitis on the Quality of Life of 6-11 Years Old Children and Caregivers (PEDI-BURDEN). Neri I, Galli E, Baiardini I, Picozza M, Rossi AB, Matruglio P, Moretti D, Cipriani F. J Asthma Allergy. 2023 Apr 12;16:383-396. doi: 10.2147/JAA.S404350. PMID: 37077900; PMCID: PMC10106808. Atopic Dermatitis and Patient Perspectives: Insights of Bullying at School and Career Discrimination at Work. Stingeni L, Belloni Fortina A, Baiardini I, Hansel K, Moretti D, Cipriani F. - J Asthma Allergy. 2021 Jul 21;14:919-928. doi: 10.2147/JAA.S317009. PMID: 34321892; PMCID: PMC8312319. Dupilumab treatment induced similar improvements in signs, symptoms, and quality of life in adults with moderate-to-severe atopic dermatitis with baseline Eczema Area and Severity Index score < 24 or ≥ 24 Annamaria Offidani, Luca Stingeni, Iria Neri, Filippo Cipriani, Zhen Chen, Ana B Rossi, Yufang Lu, Devis Moretti -Ital J Dermatol Venerol. 2022 Feb;157(1):39-46. doi: 10.23736/S2784-8671.21.06952-2. Epub 2021 Apr 21. PMID: 33878856.

Filippo Cipriani

With experience both in private and public sector, I am a Market Access – Public Affairs – Pt Advoca...
Modena, Emilia-Romagna, Italy

*50 free lookup(s) per month.

No credit card required.

Filippo Cipriani’s Email filippo.cipriani@sanofigenzyme.com

Filippo Cipriani’s Phone Numbers

Get FILIPPO’s Phone Number (For Free)

Social Media

Filippo Cipriani’s Location Modena, Emilia-Romagna, Italy

Filippo Cipriani’s Current Industry Sanofi Sanofi Genzyme

Not the Filippo Cipriani you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Sanofi

Public Affairs Lead - Specialty Care & Immunology

2020-10-01 00:00:00 - Present

Sanofi Genzyme

Project Lead MaketoCare

2015-06-01 00:00:00 - Present

Genzyme

Health Economics & Market Access Manager

2011-06-01 00:00:00 - 2016-07-01 00:00:00

Genzyme Europe

Associate Director, Market Access, EMEA

2013-10-01 00:00:00 - 2016-07-01 00:00:00

Emilia Romagna Regional Health And Social Agency

Health Economist

2008-10-01 00:00:00 - 2010-01-01 00:00:00

Glaxosmithkline

Junior Health Economist & HTA consultant

2007-05-01 00:00:00 - 2008-10-01 00:00:00

Cancer Research

Research Fellow

2001-09-01 00:00:00 - 2006-08-01 00:00:00

European Molecular Biology Laboratory

Predoctoral Research Fellow

2000-03-01 00:00:00 - 2001-08-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Filippo Cipriani

Filippo Cipriani is located at
Modena, Emilia-Romagna, Italy

Filippo Cipriani is a With experience both in private and public sector, I am a Market Access – Public Affairs – Pt Advocacy – Communication expert and enthusiast, always looking for original approaches to ameliorate people lives. In the past 15 years, I covered different roles, at national and international level, dealing with multiple therapeutic areas, developing value stories and communication campaigns, executing price (re)negotiations and supporting commercial launches in Vaccines, Rare Diseases and Rare Blood Disorders, Multiple Sclerosis, Oncology, Endocrinology and Immunology. Since 2015, I lead MAKEtoCARE, a multi-stakeholder initiative, with multiple spin-offs, to fight disability. Started as a contest to celebrate bottom-up patient-driven innovation it later evolved in a research project and in public-private alliances. Most recent papers: Implications of Atopic Dermatitis on the Quality of Life of 6-11 Years Old Children and Caregivers (PEDI-BURDEN). Neri I, Galli E, Baiardini I, Picozza M, Rossi AB, Matruglio P, Moretti D, Cipriani F. J Asthma Allergy. 2023 Apr 12;16:383-396. doi: 10.2147/JAA.S404350. PMID: 37077900; PMCID: PMC10106808. Atopic Dermatitis and Patient Perspectives: Insights of Bullying at School and Career Discrimination at Work. Stingeni L, Belloni Fortina A, Baiardini I, Hansel K, Moretti D, Cipriani F. - J Asthma Allergy. 2021 Jul 21;14:919-928. doi: 10.2147/JAA.S317009. PMID: 34321892; PMCID: PMC8312319. Dupilumab treatment induced similar improvements in signs, symptoms, and quality of life in adults with moderate-to-severe atopic dermatitis with baseline Eczema Area and Severity Index score < 24 or ≥ 24 Annamaria Offidani, Luca Stingeni, Iria Neri, Filippo Cipriani, Zhen Chen, Ana B Rossi, Yufang Lu, Devis Moretti -Ital J Dermatol Venerol. 2022 Feb;157(1):39-46. doi: 10.23736/S2784-8671.21.06952-2. Epub 2021 Apr 21. PMID: 33878856.

Filippo Cipriani currently works in the Sanofi | Sanofi Genzyme |

No Languages Available

Filippo Cipriani has prior
experience in the following industries:
Genzyme | Genzyme Europe | Emilia Romagna Regional Health And Social Agency | Glaxosmithkline | Cancer Research | European Molecular Biology Laboratory

Filippo Cipriani has the following professional experience:
Sanofi | Sanofi Genzyme | Genzyme | Genzyme Europe | Emilia Romagna Regional Health And Social Agency | Glaxosmithkline | Cancer Research | European Molecular Biology Laboratory